Skip to main
MDT

Medtronic (MDT) Stock Forecast & Price Target

Medtronic (MDT) Analyst Ratings

Based on 20 analyst ratings
Buy
Strong Buy 25%
Buy 40%
Hold 35%
Sell 0%
Strong Sell 0%

Bulls say

Medtronic is projected to achieve long-term EPS growth and has recently seen success in its Cardiac Ablation Solutions business. With key growth drivers such as renal denervation and robotics, strategic investments and planned separation of its Diabetes division, the company has potential for upside potential. However, market competition and external factors could pose risks to the company's stock price and rating.

Bears say

Medtronic is facing a number of challenges, including inconsistent execution and quarterly results, a competitive landscape in the EP market, and uncertainty surrounding the stability of its TAVR volumes. Additionally, the company's dependence on government reimbursement and its growing reliance on state supplemental programs pose risks to its financial performance. While the company has a strong product pipeline, lower cash collections and potential margin expansion challenges could hinder its growth potential. Overall, we believe that these factors will prevent Medtronic from seeing P/E multiple expansion, and therefore we have a negative outlook on the stock.

Medtronic (MDT) has been analyzed by 20 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 40% recommend Buy, 35% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Medtronic and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Medtronic (MDT) Forecast

Analysts have given Medtronic (MDT) a Buy based on their latest research and market trends.

According to 20 analysts, Medtronic (MDT) has a Buy consensus rating as of Jul 1, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $102.15, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $102.15, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Medtronic (MDT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.